NASDAQ : ATRC
AtriCure, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 61.25 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 3.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.05B |
| Enterprise Value | 2.95B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 50.87M |
| Shares Outstanding | 50.87M |
| Shares Change (YoY) | +2.50% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 4.01% |
| Owned by Institutions (%) | 112.16% |
| Float | 48.83M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 284.02 |
| Forward PE | 253.30 |
| PS Ratio | 5.35 |
| Forward PS | 4.74 |
| PB Ratio | 5.90 |
| P/TBV Ratio | 12.78 |
| P/FCF Ratio | 57.35 |
| P/OCF Ratio | 46.90 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 279.79 |
| EV / Sales | 5.18 |
| EV / EBITDA | 87.49 |
| EV / EBIT | 229.04 |
| EV / FCF | 55.58 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.22 |
| Quick Ratio | 3.02 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 2.07 |
| Debt / FCF | 1.40 |
| Interest Coverage | 2.29 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 2.15% |
| Return on Assets (ROA) | 1.25% |
| Return on Invested Capital (ROIC) | 2.67% |
| Return on Capital Employed (ROCE) | 2.17% |
| Weighted Average Cost of Capital (WACC) | 11.02% |
| Revenue Per Employee | $421,942 |
| Profits Per Employee | $7,816 |
| Employee Count | 1,350 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 1.68 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.54M |
| Effective Tax Rate | 12.75% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +73.31% |
| 50-Day Moving Average | 55.80 |
| 200-Day Moving Average | 38.18 |
| Relative Strength Index (RSI) | 57.18 |
| Average Volume (20 Days) | 704,969 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.89M |
| Short Previous Month | 4.82M |
| Short % of Shares Out | 9.61% |
| Short % of Float | 10.01% |
| Short Ratio (days to cover) | 3.46 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 569.62M |
| Gross Profit | 434.61M |
| Operating Income | 12.89M |
| Pretax Income | 12.09M |
| Net Income | 10.55M |
| EBITDA | 33.75M |
| EBIT | 12.89M |
| Earnings Per Share (EPS) | $0.21 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 167.79M |
| Total Debt | 74.22M |
| Net Cash | 93.57M |
| Net Cash Per Share | $1.84 |
| Equity (Book Value) | 516.43M |
| Book Value Per Share | 10.15 |
| Working Capital | 263.62M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 64.94M |
| Capital Expenditures | -11.83M |
| Depreciation & Amortization | 20.86M |
| Net Borrowing | 4.10M |
| Free Cash Flow | 53.11M |
| FCF Per Share | $1.04 |
Margins
| Measure | Value |
|---|
| Gross Margin | 76.30% |
| Operating Margin | 2.26% |
| Pretax Margin | 2.12% |
| Profit Margin | 1.85% |
| EBITDA Margin | 5.92% |
| EBIT Margin | 2.26% |
| FCF Margin | 9.32% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.50% |
| Shareholder Yield | -2.50% |
| Earnings Yield | 0.35% |
| FCF Yield | 1.74% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $57.56 |
| Price Target Difference | -3.87% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 12.71% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 6.77 |
| Piotroski F-Score | 8 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |